Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Articles tagged with "Safety"

Drug Updates

Michele B. Kaufman, PharmD, BCGP  |  November 1, 2011

Information on new approvals and medication safety

Drug Updates

Michele B. Kaufman, PharmD, BCGP  |  September 1, 2011

Information on new approvals and medication safety

High Cost, No Benefit

Aryeh M. Abeles, MD  |  July 12, 2011

Why are so many brand-name drugs approved after generic versions become available?

Is the Electronic Health Information in Your Practice Really Safe?

Staff  |  July 12, 2011

The Centers for Medicare and Medicaid Services (CMS) Electronic Health Record (EHR) Incentive Program (Meaningful Use) provides for eligible physicians who demonstrate “meaningful use” of certified EHR technology to be eligible to receive up to $44,000 in Medicare incentive payments over five years or up to $63,750 in Medicaid incentive payments over six years. But what does it really mean to achieve “meaningful use” for the EHR Incentive Program, and what will your practice need to do to meet the required objectives?

Drug Updates

Michele B. Kaufman, PharmD, BCGP  |  July 12, 2011

Information on New Approvals and Medication Safety

Drug Updates

Michele B. Kaufman, PharmD, BCGP  |  May 16, 2011

Information on New Approvals and Medication Safety

Opioids More Dangerous than other Analgesics for Elderly

Sue Pondrom  |  April 13, 2011

Safety events vary among different opioids

Drug UPDATES

Michele B. Kaufman, PharmD, BCGP  |  March 18, 2011

Information on New Approvals and Medication Safety

Pharma awaits FDA Guidance to Navigate the Murky Waters of Ads Via the Internet and Social Media

Vanessa Caceres  |  November 1, 2010

There’s no question that direct-to-consumer (DTC) advertising of prescription drugs is a huge activity, with nearly $5 billion spent on DTC ads in 2007. There’s also no question that the Internet has a vast potential to reach consumers. But when you put DTC advertising and the Internet together, there is a potential for problems and…

Drug Updates

Michele B. Kaufman, PharmD, BCGP  |  May 1, 2010

Information on New Approvals and Medication Safety

  • « Previous Page
  • 1
  • …
  • 9
  • 10
  • 11
  • 12
  • 13
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences